StephenMichaelGollompMD

PubMed

• Mitigating Immunogenicity by Coordinating Botulinum Toxin Treatments Between Aesthetics and Therapeutics.
  Stephen M Gollomp, Saami Khalifian, Samantha Gokhale
  Dermatologic Surgery. 2024-09-01
• 1 citations
  A Narrative Literature Review of the Established Safety of Human Serum Albumin Use as a Stabilizer in Aesthetic Botulinum Toxin Formulations Compared to Alternatives.
  Sonja Sattler, Stephen Gollomp, Andrew Curry
  Toxins. 2023-10-18
• 39 citations
  GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding
  Jay S. Schneider, Franca Cambi, Stephen Gollomp, Hiroto Kuwabara, James Robert Brašić
  Journal of the Neurological Sciences. 2015-09-15

Journal Articles

• Creatine Does Not Slow Rate of Parkinson Disease Progression  
  NET-PD Investigators, JAMA Neurol, 1/1/2015
• Measuring Disease Progression in Early Parkinson Disease The National Institutes of Health Exploratory  
  Sotirios A. Parashos, MD, PhD; Sheng Luo, MS; Kevin M. Biglan, MD, MPH; Ivan Bodis-Wollner,MD, DSc; Bo He, MS; Grace S. Liang, MD; G. Webster Ross, MD; Barbara C. Till..., JAMA Neurol, 1/1/2014
• Sustained efficacy and safety of repeated incobotulinumA (Xeomin)injections in blepharospasm  
  Truong DD, Gollomp SM, Jankovic J, LeWitt PA, Marx M, Hanschmann A, Fernandez HH; Xeomin US Blepharospasm Study Group, J Neural Transm, 1/1/2013
• A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson�s disease patients  
  Schneider, J.S., Gollomp, S.M., Sendek, S., Colcher, A., Cambi, F., and Du, W, J Neurol. Sci., 1/1/2013
• Repeatable battery for assessment of neuropsychological status in early Parkinson's disease  
  Yang, C., Garrett-Mayer, E., Schneider, J. S., Gollomp, S. M. and Tilley, B. C., Movement Disorders, 1/1/2009
• A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson�s disease  
  NINDS NET-PD Investigators, Neuorology, 1/1/2007
• A randomized, multicenter, double-blind, placebo-controlled study of botulinum toxin type A (Botox) for the treatment of cervical dystonia  
  Brin, M, and Botox 140 Study Group, Neurology, 1/1/2006
• Prevalence of headache attributed to craniocervical dystonia: An epidemiologic study  
  Molho E, Lipton RB, Bigal ME, Gollomp S, Felix C, VanDenburgh AM, Brin MF for the Headache in CD Study Group, Headache, 1/1/2006
• Hemifacial Spasm associated with Acoustic Neuroma and Tortuous Vertebral Artery  
  Kim, M, Gollomp, SM, Movement Disorders, 1/1/2006
• A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease  
  NINDS NET-PD Investigators, Neuorology, 1/1/2006
• Optimizing the ongoing search for new treatments for Parkinson disease: Using futility designs  
  B. C. Tilley, Y. Y. Palesch, K. Kieburtz, B. Ravina, P. Huang, J. J. Elm, K. Shannon, G. F. Wooten, C. M. Tanner, G. C. Goetz on behalf of the NET-PD Investigators, Neurology, 1/1/2006
• Dystonia and Headache: The response to botulinum toxin type A therapy  
  Ondo, WG, Galvez-Jimenez, N, Gollomp, SM, Headache, 1/1/2004
• Emergence of complex, involuntary movements after Gamma Knife radiosurgery for essential tremor  
  Siderowf, AD, Gollomp, SM, Stern, MB, Baltuch, GH, Riina, HA, Movement Disorders, 1/1/2001
• Binding of [Tc-99m]TRODAT-1 to dopamine transporters in patients with Parkinson�s disease and healthy volunteers  
  Mozley, PD, Schneider, JS, Acton, PD, Barraclough, ED, Stern, MB, Leopold, NA, Plossl, K, Siderowf, A, Li, PY, Gollomp, SM, Alavi, A, Kung, HF, J. Nucl. Med., 1/1/2000
• Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson�s disease  
  Hurtig, HI, Trojanowski, JQ, Galvin, J, Ewbank, D, Schmidt, ML, Lee, VM-Y, Clark, CM, Glosser, G, Stern, MB, Gollomp, SM, Arnold, SE, Neurology, 1/1/2000
• Immunohistochemical and biochemical studies demonstrate a distinct profile of a-synuclein permutations in multiple system atrophy  
  Duda, JE, Giasson, BI, Gur, TL, Montine, TJ, Robertson, D, Biaggioni, I, Hurtig, HI, Stern, MB, Gollomp SM, Grossman, M, Lee, VM-Y, Trojanowski, JQ, J Neuropath Exper Neurol, 1/1/2000
• Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy  
  Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, Biaggioni I, Hurtig HI, Stern MB, Gollomp SM, Grossman M, Lee VM, Trojanowski JQ, Journal of Neuropathology & Experimental Neurology, 1/1/2000
• Stereotactic radiosurgical pallidotomy and thalomotomy with the Gamma Knife: MR imaging findings with clinical correlation-preliminary experience  
  Friedman, D, Goldman, HW, Flanders, A, Gollomp, SM, Curran, WJ, Radiology, 1/1/1999
• Handbook of Dystonia: Volume 39-Neurological Disease and Therapy Series  
  Gollomp, SM., Neurosurgery, 1/1/1997
• Etiology of Parkinson�s Disease: Volume 40-Neurological Disease & Therapy Series  
  Gollomp, SM., Neurosurgery, 1/1/1996
• Verbal fluency deficits in parkinson's disease  
  Auriacombe, S, Grossman, M, Carvell, S, Gollomp, S, Stern, MB, Hurtig, H, Neuropsychology, 1/1/1993
• Sentence comprehension deficits in Parkinson's disease: The role of the anterior cingulate  
  Grossman, M., Crino, P., Reivich, M., Stern, M.B., Gollomp, S., Hurtig, H.I., Cerebral Cortex, 1/1/1992
• Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease  
  Doty, RL, Stern, MB, Pfeiffer, C, Gollomp, SM, and Hurtig, HI., J Neurol Neurosurg Psychiatry, 1/1/1992
• Sentence comprehension in Parkinson's disease: the role of attention and memory  
  Grossman, M., Carvell, S., Stern, M., Gollomp, S., Hurtig, H., Brain and Language, 1/1/1992
• The epidemiology of Parkinson's disease: a case-control study of young-onset and old-onset patients  
  Stern, M., Dulaney, E., Gruber, S., Golbe, L., Bergen, M., Hurtig, H., Gollomp, S., Stolley, P., Archives of Neurology, 1/1/1991
• Join now to see all

Books/Book Chapters

• Neurology of the Lower Extremities 
  Chapter: Movement Disorders of the Lower Extremities 
  Gollomp, SM.Editors: Mandel, S., McCluskey, L., and Willis, J..Churchill Livingstone, New York1999
• Understanding Sleep: The Evaluation and Treatment of Sleep Disorders 
  Chapter: Sleep and Sleep Disorders in Noncardiopulmonary Medical Disorders 
  Pressman, MR, Gollomp, S, Benz, RL, and Peterson, DD.Editors: Pressman, MR. and Orr, WC..American Psychological Association, Washington, DC1997
• Practical Neurology of the Elderly 
  Chapter: Atypical Parkinsonisms 
  Gollomp, SM, Stern, MBEditors: Sage, JI. and Mark, M..Marcel Dekker, New York1996
• Parkinsonian Syndromes 
  Chapter: Rigid Variant of Huntington's Disease 
  Gollomp, SM.Editors: Stern, M. and Koller, W..v, New York1993
• Experimental Therapeutics of Movement Disorders 
  Chapter: Therapeutic Trials in Meige Syndrome 
  Gollomp, S.M., Burke, R.E., Reches, A., Ilson, J. and Fahn, S.Editors: Shoulson, I., Fahn, S., and Calne, D..Raven Press, New York1983
• Join now to see all

Abstracts/Posters

• Clinical and neuroimaging outcomes up to 18 years after fetal tissue transplant for Parkinson�s disease
  Henchcliffe, C, Carter, J, Hanineva, A, Kang, Y, Babich, J, Gollomp, SM, Strafella, AP, Fasano, A, Ravdin, LD, Hellmers, N, Mcrae, C, Movement Disorders, 1/1/2016
• Clinical experiences with botulinum toxin type B (Myobloc) in the treatement of cervical dystonia: secondary resistance and electrophysiologic observations
  Gollomp SM, Annals of Neurology, 1/1/2003
• Paraneoplastic myelopathy secondary to adenocarcinoma of the lung
  Kim, M, Gollomp, SM, Annals of Neurology, 1/1/2002
• Effects of dopamine replacement on cognitive and motor functions in Parkinson�s disease: Correlation with [Tc-99m]TRODAT-1 labeling of striatal dopamine transporter sites
  Schneider, J.S., Ferraro, S., Gollomp, S.M., Mancall, E.L., Cambi, F., and Mozley, P.D., Soc. Neurosci., 1/1/2001
• Functional outcome after radiosurgery for tremor
  Hughes, SL, Gollomp, SM, Bednarz, G, Werner-Wasik, M, Curran, WJ, Goldman, HW, Proceedings of the 41st Annual ASTRO Meeting, IJROBP, 1/1/1999
• Results of the combined intradural/extradural rhizotomy/ramisectomy-neurectomy procedure for refractory spasmodic torticollis
  Neff S, Gollomp, S, Movement Disorders, 1/1/1998
• Recurrent life threatening polycythemic chorea successfully treated with metyrosine
  Gollomp SM, Brown, D, Movement Disorders, 1/1/1998
• Radiosurgical treatment of essential tremor
  Gollomp SM, Goldman HW, Aita A, McGlinn K, Scanlon J, Neurology, 1/1/1998
• Post-market comparison of controlled release Sinemet and standard Sinemet
  Hurtig HI, Skolnick BE, Matthews MR, Colcher A, Gollomp SM, Stern MB, Movement Disorders, 1/1/1996
• Post market comparison of controlled-release Sinemet (50/200) and standard Sinemet: a six-month follow-up study
  Hurtig HI, Matthew MR, Vernon GM, Colcher A, Sharkey MJ, Gollomp SM, Stern MB, Movement Disorders, 1/1/1994
• Olfactory function in subtypes of Parkinson's Disease
  Dotti M, Stern M, Doty R, Crawford D, Adler C, Gollomp S, and Hurtig H., Neurology, 1/1/1992
• A Case-Control Study of the Genetic Epidemiology of Parkinson's Disease
  Gruber, S., Stern, M., Dulaney, E., Golbe, L., Bergen, M., Hurtig, H., Gollomp, S., and Stolley, P., Movement Disorders, 1/1/1991
• Specific Language Impairments in Parkinson's Disease
  Grossman, M., Digby, L., Hurtig, H., Stern, M., and Gollomp, S., Neurology, 1/1/1990
• Bilateral Olfactory Dysfunction in Early Stage Medicated and Unmedicated Parkinsonism
  Doty, R., Stern, M., Pfeiffer, C., Gollomp, S., and Hurtig, H., Neurology, 1/1/1990
• The Elusive Nature of Subcortical Dementia: Definition and Clinical Usefulness in Parkinson's Disease
  Grossman, M., Hurtig, H., Stern, M., and Gollomp, S., Movement Disorders, 1/1/1990
• Dopa Responsive, Diurnally Fluctuating, Primary Writing Tremor
  Gollomp, S., Hurtig, H., Stern, M., and Vernon, G., Movement Disorders, 1/1/1990
• Correlates of clinical decline in early Parkinson`s Disease
  Parkinson Study Group, Neurology, 1/1/1987
• Is low-dose, slow-increase Bromocriptine effective in Advanced Parkinson's Disease
  Stern, M., Melvin, G., Gollomp, S.M. and Hurtig, H., Neurology, 1/1/1985
• Pharmocotherapy versus Botulinin in the Treatment of Blepharospasm: A preliminary report
  Annals of Neurology, Annals of Neurology, 1/1/1984
• Central Nervous System Whipple's Disease presenting as the Tolosa-Hunt Syndrome: Report of a Case
  Gollomp, S.M., Andersen, R.B. and Dorwart, B., Neurology, 1/1/1982
• Meige Syndrome: A Review of 31 Cases
  Gollomp, S.M., Ilson, J., Burke, R.E., Reches, A. and Fahn, S., Neurology, 1/1/1981
• Tardive Dystonia: A Persistent Dystonia due to Antipsychotic Drugs
  Burke, R.E., Fahn, S., Jankovic, J. and Gollomp, S.M., Neurology, 1/1/1981
• Join now to see all